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SHARP RNA Recognition Motif Optimizations, Exten-
sions, and Mutations for Use in 2D and 3D NMR Exper-
iments 
Shaun Christie 
University of Akron 
Abstract: SMRT/HDAC Associated Repressor Protein interacts with the long noncoding RNA, 
produced by SRA, by binding at the RRMs. Three projects were done to prepare the truncated 
proteins for use in 2D and 3D NMR experiments. The first focuses on RRM 3 and its optimiza-
tion during the purification process. The second focuses on RRM 2-4, which was found to be 
missing two alpha helices that may be important for protein stability. These helices can also in-
teract with RRM 3 as well due to the tight association of RRMs 3 and 4. The two step PCR ex-
tension of RRM 2-4 was assumed to work based on sequencing and agarose gels. The final 
project focused on serine to cysteine mutations of RRM 2 to allow site directed spin labeling for 
use in NMR PRE experiments. Both mutants developed in this project do not affect the protein 
structure or the residues surrounding the mutation based on wild type and mutant HSQC spec-
tra. The spectra of the spin labeled samples does show broadening some resonances, but may 
need reductant removed from the buffer after the labeling reaction. 
Abbreviations: PDB (protein data bank, URL: rcsb.org). PRE (paramagnetic relaxation en-
hancement). NOE (nuclear Overhauser effect). RRM (RNA recognition motif). SHARP 
(SMRT/HDAC Associated Repressor Protein). SRA (steroid receptor activator gene). IMAC 
(immobilized metal affinity chromatography). 
Introduction 
 The SMRT/HDAC Associated Repressor Protein (SHARP) contains four RNA binding domains 
that are believed to interact with the long non-coding RNA produced by the steroid receptor activator 
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Figure 1- SHARP RRM 2-4 x-ray crystallography 
structure (PDB 4P6Q). RRM 2 (blue), RRM 3 
(green), and RRM 4 (orange).  
gene (SRA). These RNA recognition motifs (RRMs) are specific and necessary for protein-RNA binding 
since deletions of the RRMs have shown a loss of interaction. SHARP and SRA RNA are involved in 
the epigenetic regulation of transcription, Notch signaling, and various cancers1. Previous experiments 
in Dr. Leeper’s lab had determined that the isolation of the protein containing all four RRMs was difficult 
under normal purification conditions. In order to study the motifs individually, site directed mutagenesis 
(SDM) was used to insert a stop codon at residues between each motif in the parent plasmid resulting 
in plasmid production for the RRMs 1, 2, 3, 4, 2-3, and 2-4. RRMs 1 and 2 have been successfully puri-
fied and concentrated for use in nuclear magnetic resonance spectroscopy (NMR). The other plasmids 
produce proteins at very low yields and only if the protein did not precipitate during the purification pro-
cess. 2D and 3D NMR experiments are used to study biomacromolecular structures and complexes, 
however, these experiments require protein samples with concentrations of at least 0.2 mM in a volume 
of 0.5 mL or more. NMR is used to determine angles, chemical shifts, and atomic distances of a mac-
romolecule in solution. When the protein is in solution it allows observation of the complex behavior 
and kinetics in real time rather than the static conformation observed by using X-ray crystallography. 
Multiple experiments are run to determine backbone and side chain resonances allowing a structure to 
be modeled from this data. The previous attempts to concentrate RRM 3 and RRM 2-4 (containing 
three of the four RRMs) resulted in aggregation of final samples or concentrations of no greater than 
0.1 mM.  
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 For the purification of RRM 3, multiple pH buffer conditions had been tested by students in Dr. 
Leeper’s group. Aggregation occurs due to the shift in the isoelectric point (pI) after cleavage of the 6-
Histidine tag used during immobilized metal affinity chromatography (IMAC) purification. These tests 
determined that a pH 6 buffer caused the least aggregation of protein. However, the first project de-
scribed here attempted to increase the concentration of the final RRM 3 product. Multiple buffer condi-
tions were tested based on the review Protein Production and Purification2.Conditions included reduct-
ant concentration, salt type, salt concentration, and addition of amino acids. The primary reductant 
used in the buffers is dithiothreitol (DTT), which prevents formation of disulfide bridges between cyste-
ine residues of the protein. RRM 3 contains three cysteine residues, two on the surface facing solution 
and one in the unstructured C-terminal region. Changes in salt type and concentration were used to 
determine whether ionic interactions cause aggregation. The addition of arginine and glutamate to the 
purification buffers deters the protein-protein aggregation by interactions with hydrophobic patches on 
the protein surface, but the exact mechanism is currently unknown. The addition of arginine and gluta-
mate does not adversely affect solution NMR or protein-RNA complexes3. 
Arieti et al. (2014)4 were able to purify the SHARP 2-4 protein for use in X-ray crystallography 
experiments. Observation of the group’s structure (Figure 1) determined that the SHARP 2-4 plasmid 
used by Dr. Leeper’s lab was missing a portion of the protein’s C-terminal end. These 27 residues 
comprise two alpha helices that may be involved in stabilizing the protein (Appendix 2: Figure 1). The 
first helix (residues 588-602) covers the beta sheet of RRM 4, which contains the proposed RNA bind-
ing site. However, other proteins exhibiting this feature undergo a conformational change that moves 
the helix out of position during RNA binding, while other proteins bind to RNA using the loop regions4. 
RRM 3 may also be stabilized by these helices. The second project reported here was used to extend 
the DNA sequence (and therefore the translated amino acid sequence) of SHARP RRM 2-4 by a two-
step PCR extension and Gateway cloning.  
 As stated above SHARP RRM 2 has been purified and used in various 2D and 3D NMR exper-
iments. The unbound structure is currently being assigned by a graduate student in Dr. Leeper’s lab. In 
order to determine the structure of the protein-RNA complex, NMR paramagnetic relaxation enhance-
ment (PRE) will be used. PRE is a useful technique for large complexes due to the lack of long range 
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nuclear overhauser effect resonances (NOEs) as the complex increases in size. NOEs allow for dis-
tances of 6 Angstroms to be measured while PREs allow distances up to 35 Angstroms. This is due to 
the addition of a spin label (here a nitroxide radical) causing a magnetic dipole interaction with the un-
paired electron and a nuclear relaxation rate increase5. The spin-labeled samples are then used in 2D 
heteronuclear single quantum coherence spectroscopy (HSQC) experiments with 15N labeled protein. 
These distances can show exactly which residues are interacting with the RNA during binding. The final 
project reported here was used to mutate and label SHARP RRM 2 for use in NMR PRE experiments 
on the SHARP RRM 2-RNA complex. 
Materials and Methods 
 Polymerase Chain Reaction (PCR) Extension: Phusion ® High-Fidelity PCR Kit (New Eng-
land Biolabs) was used for SHARP RRM 2-4 sequence extension by using the primers SHARP 2-4 N-
terminal, C-terminal 1, and C-terminal 2 (Appendix 3, Integrated DNA Technologies). Thermal cycler 
programs for each extension reaction can be found in Appendix  3. PCR reaction products were run on 
a 1% agarose gel (100 V, ~90 minutes for efficient separation) and inspected with UV light to determine 
amplicon size (in base pairs). Second extension sequence was gel extracted and purified using an Ac-
cuprep ® Gel Purification Kit (Bioneer). Samples were sent to GeneWiz Inc. for Sanger DNA sequenc-
ing using primers SHARP 2-4 N-terminal and C-terminal 2. 
 Gateway Cloning: SHARP RRM 2-4 PCR extension products were used in a Gateway ® 
Technology Cloning Kit (Invitrogen by Life Technologies). The BP reaction product was transformed 
into DH5-α competent cells. E.Z.N. A. Plasmid DNA Mini Kit II (Omega) spin protocol was used to purify 
the entry clone plasmid pDONR 221 from the colonies. The entry clone plasmid was used in the LR 
reaction to insert the SHARP RRM 2-4 sequence into an MBP-fusion vector, pDEST-HisMBP. The LR 
reaction product was transformed into One Shot ® OmniMAX TM 2 T1 Phage-Resistant E. coli cells. 
E.Z.N. A. Plasmid DNA Mini Kit II (Omega) spin protocol was used to purify the cloned plasmid from the 
colonies. Samples were sent to GeneWiz Inc. for Sanger DNA sequencing using primers MBP open 
reading frame (ORF), MBP forward insert, and MBP reverse insert (Appendix 3). Control BP reaction 
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was done using pEXP7-tet positive control. Product plasmid was transformed into DH5-α and plated on 
LB-Ampicillin plates soaked with 20 mg/ml tetracycline. 
 Site Directed Mutagenesis: SHARP RRM 2 point mutations were produced using Quikchange 
II Site Directed Mutagenesis Kit (Agilent Technologies) and primers S26C1, S26C2, S50C1, and 
S50C2 (Appendix 3, Integrated DNA Technologies). Thermal cycler program for the reaction can be 
found (Appendix). The resulting plasmid product was transformed by heat shock into XL-10 Gold com-
petent cells and plated on LB-Ampicillin. E.Z.N. A. Plasmid DNA Mini Kit II (Omega) spin protocol was 
used to purify the mutant plasmid from colonies. Samples sent to GeneWiz Inc. for Sanger DNA se-
quencing using TEV cleavage sequence primer (Appendix 3).  
Protein Expression and Purification: SHARP RRM 2 plasmids were transformed by heat 
shock into competent Escherichia coli strain BL21-DE3, a strain suitable for protein expression. After a 
30 minute incubation (37°C, 260 rpm) in 500 ul SOC media the cells were plated on LB-Ampicillin agar 
plates and incubated at 37°C overnight. One colony from a plate was transferred to 50 ml of LB-
Ampicillin media and grown overnight (37°C, 260 rpm, 12-16 hours). When an isotopic label was re-
quired, a minimal M9 media was used with 15NH4Cl as the sole nitrogen source. From the small grow 
up, 25 ml was transferred to 500 ml of LB-Ampicillin media and grown at 37°C until the absorbance at 
600 nm was 0.4-0.6 using the LB-Ampicillin media as a blank. The bacteria was induced with 50 uM 
isopropyl beta-D-1-thiogalactopyranoside (IPTG) and grown overnight (18°C, 260 rpm, 12-16 hours). 
The media was centrifuged and the supernatant media was discarded. The pellets were resuspended 
in a buffer containing 200 mM KCl, 20 mM KPhos pH 7.6, 2 mM DTT, and 20 mM imidazole and lysed 
using a French Pressure Cell. The resulting solution was centrifuged and the supernatant media was 
saved. Each protein contains a 6-histadine tag allowing for the performance of immobilized metal affini-
ty chromatography (IMAC) on the protein of interest. IMAC was run using an AKTApurifier and Frac-
920 (GE Healthcare Life Sciences). The 6-His tag binds to the nickel ions in the column and the protein 
was eluted using a second buffer containing 200 mM KCl, 20 mM KPhos pH 7.6, 2 mM DTT, and 400 
mM imidazole. The eluted protein was collected and combined for dialysis in a buffer containing 200 
mM KCl, 20 mM KPhos pH 7.6, and 2 mM DTT. All of the SHARP RRM plasmids also contain a tobac-
co etch virus (TEV) cleavage site immediately before the protein of interest. The protein was cleaved 
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from the tag using 1 OD280 of TEV protease/100 OD280 of protein after one hour of dialysis. The cleav-
age and dialysis proceeds overnight (4°C). After cleavage, a second IMAC column was performed to 
isolate the protein of interest from the tag. The eluted protein was collected and dialyzed overnight 
(4°C) to remove any residual imidazole. The dialyzed protein solution was concentrated to ~2 ml using 
an Amicon stirred cell under 60 psi nitrogen gas. 
Site Directed Spin Labeling (SDSL): Mutant SHARP RRM 2 proteins were reacted with a 10 
molar excess of (1-Oxyl-2,2,5,5-tetramethyl-delta3-pyrroline-3-methyl) Methanethiosulfonate (MTSL, 
Cayman Chemical) for 12-16 hours at 4°C6. Unreacted MTSL was removed by size exclusion chroma-
tography (SEC) using a buffer containing 80 mM KCl, 40 mM KPhos pH 7.6, and 2 mM DTT on an AK-
TAprimeplus and HiLoad 16/60 Superdex 75 prep grade SEC column (GE Healthcare Life Sciences). 
The eluted protein was collected and concentrated to ~1 ml using an Amicon stirred cell under 60 psi 
nitrogen gas. 
 15N HSQC NMR experiments: Protein samples (0.2-0.5 mM) were dialyzed against an NMR 
buffer containing 80 mM KCl, 40 mM KPhos pH 7.6, and 2 mM DTT to remove excess salt. NMR sam-
ples (500 ul) contained 8% deuterium oxide (D2O). 
15N HSQC spectra were collected using vNMRj on a 
750 MHz Varian NMR spectrometer. Spectra were processed using NMRpipe to phase, base line cor-
rect, and zero fill (size 8192). Assignments were made by using Sparky (NMRfam) by comparing the 
mutant spectra to the wild type spectrum. The same experiments were run on the spin labeled sam-
ples. 
Results and Discussion 
 SHARP RRM 3 Purification Optimization: Multiple grow ups of SHARP RRM 3 were pro-
duced by using the Protein Expression and Purification procedure described above. See Appendix 2: 
Table 1 for each buffer condition. Low salt and salt change exhibited protein aggregate during the first 
dialysis step before cleavage of the 6-His tag. The protein purified using high salt and high reductant 
buffers aggregated overnight after the first dialysis step and cleavage. Addition of arginine in the buffer 
allowed the protein to be concentrated to 57 uM without aggregation, and the addition of arginine and 
glutamate allowed the protein to be concentrated to 60 uM. Based on Arieti et al. (2014)4, SHARP RRM 
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3 is able to be purified, but in their study only supplementary circular dichroism and SEC confirmed the 
presence of RRM 3.  RRM 3 was also found to be tightly associated with RRM 4, indicating that the C-
terminal helices of RRM 4 may stabilize RRM 3. The RRM3 plasmid used by Dr. Leeper’s group was 
larger than the RRM3 plasmid purified by Arieti et al. (2014)4, containing six additional N-terminal resi-
dues and seven additional C-terminal residues (Appendix 2: Figure 2). Based on the crystal structure 
these additional residues are unstructured and include a cysteine residue. These features may have 
led to the constant aggregation and possible disulfide bond formation of the RRM 3 samples.  
SHARP RRM 2-4 PCR Extension Primer Design: Using the PDB file 4P6Q deposited by Arieti et al. 
(2014)4 it was determined that the SHARP RRM 2-4 plasmid used by Dr. Leeper’s lab exculed the C-
terminal sequence: LAFTHCMEKSQDIRDFYEMLAERREER (residues 593-620, Figure 2). Primers for 
the extension were designed so that the DNA sequence would be codon optimized for E. coli based on 
the SHARP RRM 2-4 plasmid sequence. This technique minimizes RNA secondary structure during 
transcription and translation, and limits G-rich sequences. These steps are taken so that the ribosome 
can efficiently produce the protein without errors caused by low concentration of tRNA for a non-
optimized codon or stopping due to secondary structure of the RNA. Trial and error of the codon com-
binations produced the least G-C bonds and the lowest energy RNA secondary structure (Figure 3a). 
Gateway cloning also uses specific sequences on the 5’ and 3’ ends that act as 5’ sticky ends during 
each reaction (attB flanking sites)7. The extended SHARP 2-4 sequence and the Gateway sequences 
were used as a template for the primers SHARP 2-4 N-terminal, C-terminal 1 and C-terminal 2 (Appen-
Figure 2-SHARP RRM 4 showing Dr. Leep-
er’s original plasmid (black) and the addi-
tional C-terminal helices (red). Based on 
PDB 4P6Q and generated using PyMOL 
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dix 3, Integrated DNA Technologies). SHARP 2-4 N-terminal and C-terminal 1 have an overlap region 
with the original plasmid, while C-terminal 2 has an overlap region with C-terminal 1.  
 SHARP RRM 2-4 PCR Extension Reaction: Due to the length of the additional sequence, the 
PCR was split into two reactions (Appendix 2: Figure 3). The first reaction used SHARP RRM 2-4 
plasmid and primers SHARP 2-4 N-terminal and C-terminal 1. Different reaction cycles were deter-
mined for each reaction step based on the primer overlap melting temperature and the overall primer 
melting temperature. Three cycles were used for ambient annealing, three for overlap annealing, and 
the rest for full sequence annealing. The thermal cycler program for this reaction can be found in Ap-
Figure 3- (a) Secondary structure RNA model for codons of 
the extended SHARP RRM 2-4 sequence, produced using 
RNAstructure 5.6. The secondary structure is unlikely to 
begin until approximately halfway through the sequence and 
limits the amount of potential G-C bonding. (b) Using primers 
based on this sequence, the resulting PCR extension prod-
ucts were run on an agarose gel. Lane 1 contains the ladder, 
Lane 2 contains extension two, and Lane 3 contains exten-
sion one.  
     1        2            3 
a) 
b) 
10,000 
1,500 
1,000 
900 
100 
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pendix 3: Table 2. The first reaction should produce an amplicon of 925 base pairs. The second reac-
tion used the first PCR reaction product and primers SHARP 2-4 N-terminal and C-terminal 2. The 
thermal cycler program for this reaction can be found in Appendix 3: Table 3. The second reaction 
should produce an amplicon of 983 base pairs. Both reactions were run on the 1% agarose gel (Figure 
3b). Based on this gel the second extension reaction creates an amplicon larger than the first extension 
and the product was used in subsequent experiments.  
 SHARP RRM 2-4 Gateway Cloning Reactions: Gateway cloning consists of two reactions, 
beginning with the BP reaction which inserts the attB flanked PCR product into an entry clone vector 
pDONR-211. From the entry clone vector there are multiple destination vectors that can be purchased 
for use in the LR reaction. Each reaction uses an enzyme mix containing integrase, excisionase, and 
ligase which allow the exit and entry of the sequence of interest between plasmids. The SHARP RRM 
2-4 sequence was integrated into the pDEST-HisMBP vector. The pDONR vector and pDEST vectors 
contain the gene ccdB which inhibits the growth of E. coli and is removed during the reaction. This is to 
ensure that only the plasmids that contain the gene of interest replicate in the colonies. The BP reac-
tion was incubated at room temperature for 4 hours and frozen (-20°C) until the second (LR) reaction. 
The product of the LR reaction was transformed into One Shot ® Omnimax TM 2 T1 Phage-Resistant E. 
coli cells. Plasmid isolation of three colonies were sent to GeneWiz Inc. for Sanger DNA sequencing 
using primers for MBP ORF (bp 1446-1469), MBP forward (bp 2620-2643), and MBP reverse (bp 4413-
4437, Figure 4). Results from this reaction showed that the MBP forward and reverse had no priming, 
while the MBP ORF sequence was still in the plasmid. Based on this observation a positive control BP 
reaction was performed. The BP product plasmid with the control pEXP7-tet gene should produce >100 
DH5-α colonies on LB plates soaked in 20 mg/ml tetracycline. However, the control reaction only pro-
duced eight colonies. The existence of colonies with the MBP ORF and the failure of the positive con-
trol led to the conclusion that part of the enzyme mix had been degraded since last used by members 
of Dr. Leeper’s lab. If colonies survive, but don’t contain the gene of interest, it is likely that the inte-
grase is degraded. Excisionase and ligase must be active as the ccdB suppressor gene was removed 
from the plasmid for colony survival.  
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 SHARP RRM 2-4 PCR Extension Reaction Sequencing: A second two step extension of the 
SHARP RRM 2-4 plasmid was performed and run on a 1% agarose gel. The 983 base pair band was 
excised from the gel and purified using Accuprep Gel Purification Kit (Bioneer). Appendix 2: Figure 4 
shows the absorption of the purified product. There is a large absorbance at 240 nm, assumed to be 
salt from the elution buffer of the last purification step; however, the 260 nm reading shows 51 ng 
DNA/ul. The sample was sent to Genewiz Inc. for Sanger sequencing using the SHARP 2-4 N-terminal 
and C-terminal 2 primers. The quality score for both reactions was too low to pass the quality standard, 
but usable sequence data was obtained from the C-terminal 2 sequence. This sequence was translated 
and aligned with the proposed amino acid sequence for SHARP RRM 2-4 with the additional helices for 
an 85% match in 221 residues sequenced with the extended sequence appearing at the C-terminal 
end of the protein (Appendix 2: Figure 5). If the group finds it necessary to sequence at the 5’ and 3’ 
end of the construct it is possible that internal primers will be needed, rather than the 5’ and 3’ primers 
used in these sequencing reactions. Based on these reactions and the distinct amplicon size change 
seen in the agarose gel (Figure 3b) the sequence is assumed to be extended as intended.  
Figure 4-Primer locations for Sanger sequencing of MBP-fusion vector with SHARP RRM 2-4 in-
sert. Three primers were used in each sample MBP ORF (a), MBP forward insert (b), and MBP 
reverse insert (c). attB flanking sites allow the protein of interest to be inserted between sites b 
(attR1) and c (attR2). Gene figure modified from www.addgene.org/browse/sequence/6897.  
b 
a c 
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 SHARP RRM 2 Site Directed Mutagenesis: In order to attach a spin label to a protein for PRE 
there must be a single specific site for the label to bind. No cysteine residues occur in the SHARP 2 
structure, but these can be introduced using a point mutation of a serine residue codon. Eight serine 
residues occur in the SHARP RRM 2 structure, but the mutation must be chosen carefully for correct 
labeling. Residues must have a high solvent accessibility to ensure that alkylation occurs. The residue 
must not be in an area of structural stability or activity to avoid any difference in the protein folding and 
binding once the label is bound8. The mutants for SHARP RRM 2, S26C and S50C, can be seen in 
Figure 5. S26C occurs near the end of one of the alpha helices and S50C occurs in a variable loop re-
gion. Each residue is on a separate face of the protein, but near to each other in space. Point muta-
tions were made using a Quikchange II Site Directed Mutagenesis Kit (Agilent Technologies) and the 
primers S26C1, S26C2, S50C1 and S50C2 (Appendix 3). The thermal cycler program for this reaction 
can be found in Appendix 3: Table 4. The reaction plasmid was transformed into XL-10 Gold competent 
cells and plated on LB-Ampicillin agar plates. Four plasmid isolations for each mutation (350 ul) were 
combined and spin-vacuumed for two hours to dehydrate the sample and the resulting DNA pellet was 
resuspended in 50 ul of sterile water. Each mutation plasmid was sent to Genewiz Inc. for Sanger se-
quencing with the TEV sequence primer (Appendix 3). The resulting sequences were translated and 
aligned to the wild type sequence (Appendix 2: Figure 6). Both mutations occurred at the correct resi-
due and did not affect other residues. Protein samples were prepared as stated in the Materials and 
Methods by using minimal M9 media with 15NH4Cl as the sole nitrogen source.  
Figure 5-S26C and S50C locations in SHARP 
RRM 2 structure, generated using PyMOL. 
S26C 
S50C 
  
13 
 SHARP RRM 2 Site Directed Spin Labeling: An aliquot of 1 ml of the isotopically labeled and 
concentrated protein was reacted with a 10 molar excess of MTSL from a 200 mM stock in 100% ace-
tonitrile. MTSL is similar in size and in molecular volume to a tryptophan residue and should have little 
to no effect on structure and stability of the sample9. SHARP RRM 2 S26C (0.364 mM) was reacted 
with 3.64 mM of MTSL solution. SHARP RRM 2 S50C (0.329 mM) was reacted with 3.29 mM MTSL 
solution. Each alkylation reaction (Figure 6) was incubated at 4°C for 12-16 hours and immediately 
transferred to an AKTAprimeplus and HiLoad 16/60 Superdex 75 prep grade SEC column (GE 
Healthcare Life Sciences) using the NMR buffer to remove unreacted MTSL. The eluted protein was 
collected and concentrated to ~1 ml. SHARP RRM 2 S26C had aggregation during SEC and was con-
centrated to 0.167 mM. SHARP RRM 2 S50C was concentrated to 0.217 mM.  
Figure 6-Reaction of cysteine residue the nitroxide spin label, gener-
ated using ChemDraw 13.0. Unreacted MTSL and the resulting by-
product were separated from the protein by SEC. 
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 SHARP RRM 2 15N HSQC NMR: Protein NMR samples (500 ul) contained 8% D2O. S26C and 
S50C samples were run before adding spin label to ensure that most resonances were not shifted and 
a) 
b) 
Figure 7- 15N HSQC data for mutants samples before MTSL addition with wild type spectra in black 
and mutant spectra in red. (A) shows SHARP RRM 2 S26C spectrum and (b) shows SHARP RRM 
2 S50C spectrum. The SHARP RRM 2 15N HSQC NMR section of Results and Discussion explains 
where resonances were shifted. Figures generated by using Sparky (NMRfam). 
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new residue assignments would not be necessary. SHARP RRM 2 S26C non spin-labeled HSQC 
showed shifts in 25T, 27L, 28K, and a new resonance, which does not appear in the wild type spec-
trum, that may be 24D (Figure 7a). The resonance that is shifted in the nitrogen dimension from the 
wild type 26S resonance is presumed to be 26C. SHARP RRM 2 S50C non spin-labeled HSQC shows 
shifts in 46I, 49T, 53R, and 54Y (Figure 7b). The resonance that is shifted in the nitrogen dimension 
from the wild type 50S resonance is presumed to be 50C. S26C and S50C samples were also run after 
the spin labeling reaction to observe the broadening of peaks due to PRE and as a comparison for the 
RNA bound spectra. Spin labeled samples were run using the same procedure, however, the concen-
tration of both samples was lower after the labeling reaction. SHARP RRM 2 S26C spin labeled HSQC 
showed loss of resonance for residues 21R, 22S, 25T, 50S, 55G,78F, 79G, and 93E (data not shown). 
SHARP RRM 2 S50C spin labeled HSQC showed loss of resonance for residues 6E, 9K, 74G, 78F, 
and 93E (data not shown). 
Conclusions 
 Determining the structure of the unbound and RNA bound RRMs is necessary to understand 
how the interactions occur and change conformation of both the RNA and protein affects the signaling 
pathways. These research projects were focused on preparing the truncated RRMs for 2D and 3D 
NMR experiments. RRM 3 was difficult to purify using the procedure used for SHARP RRM 1 and 2. 
The optimization of the RRM was relatively unsuccessful, but the addition of arginine and glutamate did 
allow a small concentration of protein to survive the purification process. However, recent research has 
shown that RRM 3 and RRM 4 are tightly associated and the C-terminal helices of RRM 4 may stabilize 
the protein4. Based on this research, focus was shifted to obtaining a SHARP RRM 2-4 plasmid that 
contained the missing C-terminal helices, by using PCR extension and Gateway cloning. The PCR re-
actions to extend the plasmid are assumed to have worked based on agarose gel and partial sequenc-
ing data. Research on RRM 2-4 will continue once a new Gateway ® Technology Cloning Kit (Invitro-
gen by Life Technologies) is purchased by adopting the primers and techniques discussed in this re-
port. The protein purification will be attempted using the buffer system in Arieti et al. (2014)4, and used 
in various 2D and 3D NMR experiments to determine the unbound and RNA bound structures. RRM 2 
cysteine mutations for NMR PRE were successful and based on the non spin-labeled 15N HSQC spec-
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tra for S26C and S50, do not affect the protein overall structure. Spectra of the MTSL labeled protein 
show loss of some resonances, but this may be due to the lower concentration of the samples obtained 
after the labeling reaction. The current experiment focuses on increased T2 relaxation times to deter-
mine if 15N HSQC resonances near the spin label broaden faster than those at a larger distance. Fur-
ther analysis can be done by using mass spectrometry to determine the molecular weight of the spin 
labeled samples. MTSL should increase the molecular weight of the protein by 185 g/mol. One of the 
unsolved problems with the NMR experiments is the optimization of salt concentration, which could in-
crease resolution if the salt concentration is decreased. Further research with the cysteine mutants will 
include RNA-bound complex structures and include analysis of the spin labeled protein with unlabeled 
RNA and unlabeled protein with spin labeled RNA. This will require structure assignments for each 
RNA fragment used which has yet to be completed by Dr. Leeper’s group. However, the cysteine mu-
tants can also be fluorescently labeled with thiol-reactive dyes and used in RNA footprinting experi-
ments without assignments for the RNA structure. Electron paramagnetic resonance (EPR) and double 
electron-electron resonance (DEER) spectroscopy with nitroxide spin labeled cysteine mutants can al-
so be performed for additional complex structure determination methods10,11. Cysteine mutants will also 
be made for SHARP RRM 1, which does not contain cysteine residues and has four potential serine 
residues for mutation. The same labeling experiments can then be run using with RRM 1 and the asso-
ciated RNA fragments. 
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Appendix 1: Safety Information 
Equipment Training-Most equipment training was received from University of Akron graduate 
student Joel Caporoso. Potential hazardous equipment included, but not limited to; French 
pressure cell (which uses up to 1200 psi to lyse cells), high speed centrifuge (if incorrectly bal-
anced), and NMR magnets (which can pull in loose metallic objects). Autoclave training was 
provided by Dr. Hazel Barton of the University of Akron Biology Department.  
Chemical safety-Gloves and googles were worn when working with any chemical substanc-
es. Sulfur containing solutions such as DTT, BME, and MTSL were used in the chemical hood to 
prevent eye and nasal irritation and colleagues were alerted of the chemical being used. Pipette 
tips are disposed of in cardboard or Styrofoam boxes. Syringe needles are disposed of in metal 
containers to avoid punctures that would occur if disposed in plastic or cardboard. Buffer sys-
tems used in IMAC FPLC and NMR were disposed of in the sink with copious amounts of water. 
Ethinium bromide, used in DNA-binding in agarose gel, was added to the gel solution and the 
flasks were washed immediately. Agarose gels are disposed of by allowing them to dry out. Hal-
ogen and non-halogen waste containers are located in the flammable solvent cabinet and dis-
posed of by the Department of Environmental and Occupational Health and Safety. 
Biohazard safety-Gloves and googles were worn when working with any biological substanc-
es. Pipette tips that come in contact with bacteria or bacterial media are disposed of in a sepa-
rate tip box than chemical tips. LB-agar plates that have been used for bacteria growth were 
disposed of in a specific biohazard waste container. Waste containers are disposed of by the 
Department of Environmental and Occupational Health and Safety. Bacterial media is diluted 
with bleach in the bottle or flask after use to deter any further growth and disposed of in the sink 
with copious amounts of water.  
NMR Lab safety-The magnetic field of the 750 MHz NMR exerts a large force and may pull 
loose metallic objects, due to the NMR remaining on when not running an experimental sample. 
2 
 
The physical magnet has a large current running through it and is cooled by large amounts of 
liquid nitrogen and helium, which will evaporate if a leak occurs in the shielding. Liquid helium is 
approximately -269°C and liquid nitrogen is approximately -196°C. 
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Supplementary Figure 1-Rotated view of 
SHARP RRM 4 to show the residues (green) 
which may interact between the C-terminal 
helix and the beta sheet surface. Generated 
using PyMOL based on PDB 4P6Q. 
Supplementary Figure 2-SHARP RRM 3 
(black) with the unstructured regions (red) that 
could decrease stability and were not present 
in the Arieti et al. (2014) truncated plasmid. 
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a) 
b) 
Supplementary Figure 3- Two step PCR extension of SHARP RRM 2-4 DNA sequence. a). Reaction 
one using primer N-terminal and C-terminal 1. attB1 flanking site is added to the 5’ end of the se-
quence, overlapping with the TEV protease cleavage site. Red sequence indicates codons that are part 
of the C-terminal alpha helices. b). Reaction two using primers N-terminal and C-terminal two. attB2 
flanking site is added to the 3’ end of the sequence overlapping with the extended sequence from reac-
tion one. 
Supplementary Figure 4-Nanodrop absorbance curve of the gel purified 
SHARP RRM 2-4 PCR extension two product. The large absorbance at 230-
240 nm is most likely salt from the purification kit’s elution buffer. 
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Supplementary Figure 5- BLAST alignment of SHARP RRM 2-4 proposed sequence (Query) 
and the translated C-terminal 2 Sanger sequencing results (Sbjct). An 85% match occurred 
with two gaps present. The extended amino acid sequence begins at residue 268 on the que-
ry and 233 on the subject.  
Supplementary Figure 6-BLAST Alignment of SHARP RRM 2 S26C (a) and S50C (b) with 
the wild type sequence (Query) and the translated Sanger sequencing results for S26C 
and S50C (Sbjct). Both contain the intended mutation with no effect on the surrounding 
residues. 
a) 
b) 
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Buffer Components 
Final SHARP RRM 3 
Concentration 
RRM 3 Original 
Buffer 200 mM KCl, 20 mM KPhos (pH 6), 2 mM DTT <0.1 mM in ~0.5 ml 
High Reductant 200 mM KCl, 20 mM KPhos (pH 6), 4 mM DTT 
Aggregated after di-
alysis and cleavage 
Salt Change 200 mM NaCl, 20 mM NaPhos (pH 6), 2 mM DTT 
Aggregated during 
cleavage 
High Salt 400 mM NaCl, 20 mM NaPhos (pH 6), 2 mM DTT 
Aggregated after di-
alysis and cleavage 
Low Salt 80 mM NaCl, 20 mM NaPhos (pH 6), 2 mM DTT 
Aggregated during 
cleavage 
Addition of Arginine 
200 mM NaCl, 20 mM NaPhos (pH 6), 2 mM DTT, 100 
mM arginine, 99% L(+) 0.0574 mM in ~4 ml 
Addition of Arginine 
and Glutamate 
200 mM NaCl, 20 mM NaPhos (pH 6), 2 mM DTT, 50 
mM arginine 99% L(+), 50 mM glutamate L(+) 
0.062 mM in ~1.5 ml 
with some aggrega-
tion 
 
Supplementary Table 1-Buffer systems used in SHARP RRM 3 optimization experiments and the 
resulting protein concentration or failure. 
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Appendix 3: PCR Primer Sequences and Programs 
 
SHARP 2-4 N-terminal 
 
5’ GGG GAC AAG TTT GTA CAA AAA AGC AGG C 3’ 
 
SHARP 2-4 C-terminal 1 
 
5’ TTC ATA AAA ATC ACG AAT ATC TTG ACC GG 3’ 
 
SHARP 2-4 C-terminal 2 
 
5’ GGG GAC CAC TTT GTA CAA AGC TGG GTT A 3’ 
 
SHARP 2 S26C primer 1 
 
5’ GCC GTC TTT CAG GCA CGT ATC CGT CGA A 3’ 
 
SHARP 2 S26C primer 2 
 
5’ CGT TCG ACG GAT ACG TGC CTG AAA GAC G 3’ 
 
SHARP 2 S50C primer 1 
 
5’ CAT AAC GTT CTT CGC AGG TGC CGT GAA TC 3’ 
 
SHARP 2 S50C primer 2 
 
5’ CCA GAT TCA CGG CAC CTG CGA AGA ACG T 3’ 
 
TEV sequence 
 
5’ GAA AAT CTG TAC TTC CAG 3’ 
 
MBP ORF  
 
5’ GAG CGG ATA ACA ATT TCA CAG AGG 3’ 
 
MBP forward  
 
5’ GAT GAA GCC CTG AAA GAC GCG CAG 3’ 
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MBP reverse 
 
5’ GCA AGG CGA TTA AGT TGG GTA ACG C 3’ 
 
Cycle Step Number of Cycles Temperature (°C) Time (seconds) 
Initial Denaturation 1 98 30 
Denaturing 
3 
98 10 
Annealing 25 15 
Extension 72 20 
Denaturing 
3 
98 10 
Annealing 57.3 15 
Extension 72 20 
Denaturing 
23 
98 10 
Annealing 71.6 15 
Extension 72 20 
Final Extension 1 72 300 
Hold 1 4   
 
 
 
Cycle Step Number of Cycles Temperature (°C) Time (seconds) 
Initial Denaturation 1 98 30 
Denaturing 
3 
98 10 
Annealing 25 15 
Extenision 72 20 
Denaturing 
3 
98 10 
Annealing 46.9 15 
Extenision 72 20 
Denaturing 
23 
98 10 
Annealing 72.8 15 
Extenision 72 20 
Final Extension 1 72 300 
Hold 1 4   
 
 
 
Supplementary Table 2-Thermal cycler program for PCR extension reaction one. The 
first three cycle period was used as an ambient annealing temperature, the second 
three cycle period as an overlap annealing temperature, and the twenty three cycle pe-
riod as full primer annealing. 
Supplementary Table 3-Thermal cycler program for PCR extension reaction two. The 
first three cycle period was used as an ambient annealing temperature, the second 
three cycle period as an overlap annealing temperature, and the twenty three cycle pe-
riod as full primer annealing. 
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Cycle Step Number of Cycles Temperature (°C) Time (minutes) 
Initial Denaturation 1 95 0.5 
Denaturing 
14 
95 0.5 
Annealing 55 1 
Extenision 68 6 
Hold 1 4   
 
 
 
Supplementary Table 4-Thermal cycler program for Quikchange Site Directed Muta-
genesis protocol. The number of cycles depends on plasmid and vector length. 
